These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 39117919)
21. Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling. Johansson-Percival A; Ganss R Front Immunol; 2021; 12():674375. PubMed ID: 34122434 [TBL] [Abstract][Full Text] [Related]
22. Tertiary lymphoid structures in cancer: maturation and induction. Chen Y; Wu Y; Yan G; Zhang G Front Immunol; 2024; 15():1369626. PubMed ID: 38690273 [TBL] [Abstract][Full Text] [Related]
23. T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle. Lin WP; Li H; Sun ZJ EBioMedicine; 2024 Jun; 104():105154. PubMed ID: 38749300 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of tertiary lymphoid structure formation: cooperation between inflammation and antigenicity. Khanal S; Wieland A; Gunderson AJ Front Immunol; 2023; 14():1267654. PubMed ID: 37809103 [TBL] [Abstract][Full Text] [Related]
26. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Liu Z; Meng X; Tang X; Zou W; He Y Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914 [TBL] [Abstract][Full Text] [Related]
27. [Tertiary lymphoid structures in cancer: From biology to therapeutic guides]. Quesada S; Lebreton C; Caux C; Italiano A; Dubois B Bull Cancer; 2023 Jun; 110(6):657-664. PubMed ID: 37150731 [TBL] [Abstract][Full Text] [Related]
28. Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Petroni G; Pillozzi S; Antonuzzo L Cancer Res; 2024 Apr; 84(8):1199-1209. PubMed ID: 38381540 [TBL] [Abstract][Full Text] [Related]
29. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation. Salem D; Chelvanambi M; Storkus WJ; Fecek RJ Front Immunol; 2021; 12():629519. PubMed ID: 33746966 [TBL] [Abstract][Full Text] [Related]
30. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma. Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354 [TBL] [Abstract][Full Text] [Related]
31. Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy. Aoyama S; Nakagawa R; Mulé JJ; Mailloux AW Front Immunol; 2021; 12():675538. PubMed ID: 34054863 [TBL] [Abstract][Full Text] [Related]
32. Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer. Esparcia-Pinedo L; Romero-Laorden N; Alfranca A Front Immunol; 2023; 14():1231315. PubMed ID: 37622111 [TBL] [Abstract][Full Text] [Related]
33. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue? Siliņa K; Rulle U; Kalniņa Z; Linē A Cancer Immunol Immunother; 2014 Jul; 63(7):643-62. PubMed ID: 24695950 [TBL] [Abstract][Full Text] [Related]
34. Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis. Zhang X; Yao J; Xie M; Liang Y; Lin X; Song J; Bao X; Ma X; Wang Y; Zhang Y; Liu Y; Han W; Pan L; Xue X Int Immunopharmacol; 2024 Oct; 140():112790. PubMed ID: 39088920 [TBL] [Abstract][Full Text] [Related]
35. Harnessing the power of oncolytic virotherapy and tertiary lymphoid structures to amplify antitumor immune responses in cancer patients. Houel A; Foloppe J; Dieu-Nosjean MC Semin Immunol; 2023 Sep; 69():101796. PubMed ID: 37356421 [TBL] [Abstract][Full Text] [Related]
36. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma. Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353 [TBL] [Abstract][Full Text] [Related]
37. The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer. van Dijk N; Gil-Jimenez A; Silina K; van Montfoort ML; Einerhand S; Jonkman L; Voskuilen CS; Peters D; Sanders J; Lubeck Y; Broeks A; Hooijberg E; Vis DJ; van den Broek M; Wessels LFA; van Rhijn BWG; van der Heijden MS Front Immunol; 2021; 12():793964. PubMed ID: 34987518 [TBL] [Abstract][Full Text] [Related]
38. Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer. Vaccaro A; van de Walle T; Ramachandran M; Essand M; Dimberg A Front Immunol; 2023; 14():1275378. PubMed ID: 37954592 [TBL] [Abstract][Full Text] [Related]
39. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice. Delvecchio FR; Fincham REA; Spear S; Clear A; Roy-Luzarraga M; Balkwill FR; Gribben JG; Bombardieri M; Hodivala-Dilke K; Capasso M; Kocher HM Cell Mol Gastroenterol Hepatol; 2021; 12(5):1543-1565. PubMed ID: 34252585 [TBL] [Abstract][Full Text] [Related]
40. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application. Zhang Y; Xu M; Ren Y; Ba Y; Liu S; Zuo A; Xu H; Weng S; Han X; Liu Z Mol Cancer; 2024 Apr; 23(1):75. PubMed ID: 38582847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]